Resultados da busca - Simon Hitier

  • Mostrando 1 - 6 resultados de 6
Refinar Resultados
  1. 1
    Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: Results of the European compassionate-use programme

    Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: Results of the European compassionate-use programme por Axel Heidenreich, Sergio Bracarda, Malcolm D. Mason, Haluk Özen, Lisa Sengeløv, Inge M. van Oort, Christos N. Papandreou, Sophie D. Fosså, Simon Hitier, Miguel Ángel Climent

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  2. 2
    21st century headache: mapping new territory

    21st century headache: mapping new territory por Peter J. Goadsby, Michel Lantéri‐Minet, Martin C. Michel, Mário Fernando Prieto Peres, Mamoru Shibata, Andreas Straube, Tissa Wijeratne, Caty Ebel‐Bitoun, Luminita Constantin, Simon Hitier

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  3. 3
    Safety of Cabazitaxel + Prednisone (Cbz + P) in Patients (Pts) with Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Previously Treated with Docetaxel (Doc): Cohort Compassionate-Use Programme (Cup)

    Safety of Cabazitaxel + Prednisone (Cbz + P) in Patients (Pts) with Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Previously Treated with Docetaxel (Doc): Cohort Compassi... por Axel Heidenreich, H Scholz, Hasan Özen, Choosak Pripatnanont, Inge M. van Oort, Winald R. Gerritsen, Eleni Efstathiou, José Augusto Rinck, Jeong Hyun Lee, A. Boumessous, Zhen Su, Simon Hitier, Alexandros Ardavanis

    Publicado em 2014
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  4. 4
    Treatment Patterns in Patients (Pts) with Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Previously Treated with Docetaxel (Doc)-Based Chemotherapy (Ctx): Proxima

    Treatment Patterns in Patients (Pts) with Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Previously Treated with Docetaxel (Doc)-Based Chemotherapy (Ctx): Proxima por Hideyuki Akaza, Giuseppe Procopio, Choosak Pripatnanont, Gaetano Facchini, S. Fava, Duncan Wheatley, K.C. Leung, Mohammad Butt, A. Silva, Lucía Castillo, George Fountzilas, Simon Hitier, Evelyne Ecstein-Fraïsse, Samira Bensfia, Mustafa Özgüroğlu

    Publicado em 2014
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  5. 5
    Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study

    Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study por Eric Van Cutsem, C. Boni, Josep Tabernero, Bartomeu Massutí, Gary Middleton, Faysal Dane, Peter Reichardt, Francisco Pimentel, Allen Lee Cohn, Philippe Follana, Michael Clemens, Alberto Zaniboni, Vladimir Moiseyenko, Mark Harrison, Donald Richards, Hans Prenen, Simon Pernot, Evelyne Ecstein-Fraïsse, Simon Hitier, P. Rougier

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  6. 6
    Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial

    Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized tr... por John R. Mackey, Tadeusz Pieńkowski, John Crown, Saeed Sadeghi, Miguel Martín, Arlene Chan, Mansoor N. Saleh, Sandeep Sehdev, Louise Provencher, Semiglazov Vf, Michael F. Press, Guido Sauter, Mary-Ann Lindsay, Vincent Houé, Marc Buyse, Philippe Drevot, Simon Hitier, Samira Bensfia, W. Eiermann

    Publicado em 2016
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: